What is ImmunityBio, Inc.'s investing cash flow?

ImmunityBio, Inc. (IBRX) reported investing cash flow of -$31.65M in Q1 2026.

How has ImmunityBio, Inc.'s investing cash flow changed year-over-year?

ImmunityBio, Inc.'s investing cash flow decreased by 866.5% year-over-year, from $4.13M to -$31.65M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

ImmunityBio, Inc. IBRX Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

Johnson & JohnsonJNJ

-$1.04B-250%

Merck & Co.MRK

-$10.21B-587%

Gilead SciencesGILD

$1.77B+527%

Immunovant, Inc.IMVT

——

Kymera TherapeuticsKYMR

——

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s investing cash flow?: ImmunityBio, Inc. (IBRX) reported investing cash flow of -$31.65M in Q1 2026.
How has ImmunityBio, Inc.'s investing cash flow changed year-over-year?: ImmunityBio, Inc.'s investing cash flow decreased by 866.5% year-over-year, from $4.13M to -$31.65M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.